Zhang Lei, Tang Fengyuan, Terracciano Luigi, Hynx Debby, Kohler Reto, Bichet Sandrine, Hess Daniel, Cron Peter, Hemmings Brian A, Hergovich Alexander, Schmitz-Rohmer Debora
Friedrich Miescher Institute for Biomedical Research, Maulbeerstrasse 66, 4058 Basel, Switzerland.
Institute of Pathology, University of Basel, Schoenbeistrasse 40, 4031 Basel, Switzerland.
Curr Biol. 2015 Feb 2;25(3):296-305. doi: 10.1016/j.cub.2014.11.054. Epub 2015 Jan 15.
Phosphorylation of the transcriptional coactivator YAP1 is a key event in defining Hippo signaling outputs. Previous studies demonstrated that phosphorylation of YAP1 at serine 127 (S127) sequesters YAP1 in the cytoplasm and consequently inhibits YAP1 transcriptional activity. Mammalian tissue-culture experiments suggest that downstream of MST1/2 signaling, LATS1/2 function as YAP1-S127 kinases. However, studies of Mst1/2 knockout mouse models revealed that the identity of the physiological YAP1-S127 kinase(s) in certain tissues, such as the intestine, remains unknown.
We show that mammalian NDR1/2 kinases phosphorylate YAP1 on S127 and thereby negatively regulate YAP1 activity in tissue-cultured cells. By studying NDR1/2-deficient mice, we demonstrate the in vivo relevance of NDR1/2-mediated regulation of YAP1. Specifically, upon loss of NDR1/2 in the intestinal epithelium, endogenous S127 phosphorylation is decreased whereas total YAP1 levels are increased. Significantly, ablation of NDR1/2 from the intestinal epithelium renders mice exquisitely sensitive to chemically induced colon carcinogenesis. Analysis of human colon cancer samples further revealed that NDR2 and YAP1 protein expression are inversely correlated in the majority of samples with high YAP1 expression. Collectively, we report NDR1/2 as physiological YAP1-S127 kinases that might function as tumor suppressors upstream of YAP1 in human colorectal cancer.
We establish mammalian NDR1/2 as bona fide kinases that target YAP1 on S127 in vitro and in vivo. Our findings therefore have important implications for a broad range of research efforts aimed at decoding and eventually manipulating YAP1 biology in cancer settings, regenerative medicine, and possibly also noncancer human diseases.
转录共激活因子YAP1的磷酸化是定义Hippo信号输出的关键事件。先前的研究表明,YAP1丝氨酸127(S127)位点的磷酸化将YAP1隔离在细胞质中,从而抑制YAP1的转录活性。哺乳动物组织培养实验表明,在MST1/2信号下游,LATS1/2作为YAP1-S127激酶发挥作用。然而,对Mst1/2基因敲除小鼠模型的研究表明,某些组织(如肠道)中生理性YAP1-S127激酶的身份仍然未知。
我们发现哺乳动物NDR1/2激酶可使YAP1的S127位点磷酸化,从而在组织培养细胞中负向调节YAP1活性。通过研究NDR1/2缺陷小鼠,我们证明了NDR1/2介导的YAP1调节在体内的相关性。具体而言,肠道上皮中NDR1/2缺失时,内源性S127磷酸化水平降低,而YAP1总水平升高。值得注意的是,肠道上皮中NDR1/2的缺失使小鼠对化学诱导的结肠癌发生异常敏感。对人类结肠癌样本的分析进一步显示,在大多数YAP1高表达的样本中,NDR2和YAP1蛋白表达呈负相关。总体而言,我们报告NDR1/2作为生理性YAP1-S127激酶,可能在人类结直肠癌中作为YAP1上游的肿瘤抑制因子发挥作用。
我们确定哺乳动物NDR1/2是在体外和体内靶向YAP1的S127位点的真正激酶。因此,我们的发现对于旨在解码并最终在癌症、再生医学以及可能的非癌性人类疾病中操控YAP1生物学特性的广泛研究工作具有重要意义。